Purinergic contribution to small intestinal afferent hypersensitivity in a murine model of postinfectious bowel

W Rong1, C Keating, B Sun

  • 1Department of Physiology, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Insights

Purinergic receptors P2X(2) and P2X(3) do not affect normal gut mechanosensitivity. However, these receptors significantly contribute to hypersensitivity in post-infectious gut dysfunction, suggesting a therapeutic target for visceral pain.

Area of Science:

  • Gastroenterology
  • Neuroscience
  • Pharmacology

Background:

  • Functional bowel disorders are linked to heightened sensitivity of gastrointestinal afferent nerves.
  • Purinergic receptors, specifically P2X(2) and P2X(3) subunits, are implicated in sensory pathways.

Purpose of the Study:

  • To investigate the role of P2X(2) and P2X(3) receptor subunits in small intestinal mechanosensitivity.
  • To determine if these receptors contribute to hypersensitivity in a mouse model of post-infectious gut dysfunction.

Main Methods:

  • Recorded mesenteric afferent nerve activity in an in vitro mouse jejunum preparation.
  • Utilized gene-deficient mice lacking P2X(2) and P2X(3) subunits.
  • Administered P2X/P2Y antagonist (PPADS) and selective P2X(3) antagonist.
  • Compared responses in normal mice and mice infected with Trichinella spiralis.

Main Results:

  • Absence of P2X(2) and P2X(3) subunits did not alter normal jejunal mechanosensitivity.
  • Pharmacological antagonism of P2X receptors had no effect on mechanosensitivity in wild-type mice.
  • Post-infectious gut dysfunction model showed increased afferent responses to distension.
  • PPADS significantly inhibited this hypersensitivity in infected mice.

Conclusions:

  • Purinergic mechanisms are not involved in normal small intestinal mechanosensory transduction.
  • P2X(2) and P2X(3) receptors play a significant role in the development of post-infectious gut mechano-hypersensitivity.
  • Targeting these purinergic receptors may offer a therapeutic strategy for visceral pain in functional bowel disorders.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...